{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:43:01Z","timestamp":1792600981532,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02396-0","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:15:07Z","timestamp":1784978107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genistein Has Beneficial Effects Against Non-Alcoholic Fatty Liver Disease Through Activation of the SIRT1\/PPAR-\u03b1\/PGC-1\u03b1 and Nrf2 Signaling Pathways"],"prefix":"10.1007","volume":"49","author":[{"given":"Fahimeh","family":"Zamani-Garmsiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnaz","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadra Samavarchi","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShadiSadat","family":"Seyyedebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Bahramzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Meshkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"2396_CR1","doi-asserted-by":"publisher","first-page":"121706","DOI":"10.1016\/j.lfs.2023.121706","volume":"323","author":"SS Tehrani","year":"2023","unstructured":"Tehrani, S. S. et al. 2023. The combination of Metformin with Morin alleviates hepatic steatosis via modulating hepatic lipid metabolism, hepatic inflammation, brown adipose tissue thermogenesis, and white adipose tissue Browning in high-fat diet-fed mice. Life Sciences 323:121706.","journal-title":"Life Sciences"},{"key":"2396_CR2","doi-asserted-by":"publisher","first-page":"109369","DOI":"10.1016\/j.jnutbio.2023.109369","volume":"118","author":"G Goodarzi","year":"2023","unstructured":"Goodarzi, G. et al. 2023. Combination therapy of Metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL\/6 mice. The Journal of Nutritional Biochemistry 118:109369.","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"1","key":"2396_CR3","first-page":"76","volume":"8","author":"R Kumar","year":"2020","unstructured":"Kumar, R., R. N. Priyadarshi, and U. Anand. 2020. Non-alcoholic fatty liver disease: Growing burden, adverse outcomes and associations. Journal of Clinical and Translational Hepatology 8(1):76.","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"27","key":"2396_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4254\/wjh.v8.i27.1137","volume":"8","author":"I Croci","year":"2016","unstructured":"Croci, I. et al. 2016. Independent effects of diet and exercise training on fat oxidation in non-alcoholic fatty liver disease. World Journal of Hepatology 8(27):1137.","journal-title":"World Journal of Hepatology"},{"key":"2396_CR5","doi-asserted-by":"publisher","first-page":"33102","DOI":"10.1038\/srep33102","volume":"6","author":"J-H Ye","year":"2016","unstructured":"Ye, J.-H. et al. 2016. Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid \u03b2-oxidation. Scientific Reports 6:33102.","journal-title":"Scientific Reports"},{"key":"2396_CR6","doi-asserted-by":"crossref","unstructured":"Moore, M. P. et al. 2022. Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD. 76(5): pp. 1452\u20131465.","DOI":"10.1002\/hep.32324"},{"key":"2396_CR7","doi-asserted-by":"crossref","unstructured":"Tahri-Joutey, M. et al. 2021. Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPAR\u03b1. 22(16): p. 8969.","DOI":"10.3390\/ijms22168969"},{"key":"2396_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7403230","author":"T Mello","year":"2016","unstructured":"Mello, T., M. Materozzi, and A. Galli. 2016. PPARs and mitochondrial metabolism: From NAFLD to HCC. PPAR Research. https:\/\/doi.org\/10.1155\/2016\/7403230.","journal-title":"PPAR Research"},{"issue":"1","key":"2396_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-15-1106","volume":"15","author":"E Szalowska","year":"2014","unstructured":"Szalowska, E. et al. 2014. Transcriptomic signatures of peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) in different mouse liver models identify novel aspects of its biology. BMC Genomics 15(1):1\u201314.","journal-title":"BMC Genomics"},{"issue":"5","key":"2396_CR10","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1159\/000493650","volume":"49","author":"C-J Liou","year":"2018","unstructured":"Liou, C.-J. et al. 2018. Fisetin protects against hepatic steatosis through regulation of the Sirt1\/AMPK and fatty acid \u03b2-oxidation signaling pathway in high-fat diet-induced obese mice. Cellular Physiology and Biochemistry 49(5):1870\u20131884.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"2396_CR11","doi-asserted-by":"crossref","unstructured":"Pang, J. et al. 2024. Sirt1-mediated deacetylation of PGC-1\u03b1 alleviated hepatic steatosis in type 2 diabetes mellitus via improving mitochondrial fatty acid oxidation. 124: p. 111478.","DOI":"10.1016\/j.cellsig.2024.111478"},{"issue":"18","key":"2396_CR12","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.3748\/wjg.v26.i18.2203","volume":"26","author":"F-Z Xin","year":"2020","unstructured":"Xin, F.-Z. et al. 2020. Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPAR\u03b1. World Journal of Gastroenterology 26(18):2203.","journal-title":"World Journal of Gastroenterology"},{"key":"2396_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6889533","author":"T Hong","year":"2021","unstructured":"Hong, T., et al. 2021. The role and mechanism of oxidative stress and nuclear receptors in the development of NAFLD. Oxidative Medicine and Cellular Longevity. https:\/\/doi.org\/10.1155\/2021\/6889533.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"2396_CR14","doi-asserted-by":"publisher","first-page":"105667","DOI":"10.1016\/j.biocel.2019.105667","volume":"119","author":"H Hosseini","year":"2020","unstructured":"Hosseini, H. et al. 2020. Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway. The International Journal of Biochemistry & Cell Biology 119:105667.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"36","key":"2396_CR15","doi-asserted-by":"publisher","first-page":"13079","DOI":"10.3748\/wjg.v20.i36.13079","volume":"20","author":"W Tang","year":"2014","unstructured":"Tang, W. et al. 2014. Role of Nrf2 in chronic liver disease. World Journal of Gastroenterology: WJG 20(36):13079.","journal-title":"World Journal of Gastroenterology: WJG"},{"issue":"3","key":"2396_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/iub.2221","volume":"72","author":"M Teimouri","year":"2020","unstructured":"Teimouri, M. et al. 2020. Inhibiting miR-27a and miR\u2010142\u20105p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway. IUBMB Life 72(3):361\u2013372.","journal-title":"IUBMB Life"},{"issue":"7","key":"2396_CR17","doi-asserted-by":"publisher","first-page":"852","DOI":"10.7150\/ijbs.19370","volume":"13","author":"R-B Ding","year":"2017","unstructured":"Ding, R.-B., J. Bao, and C.-X. Deng. 2017. Emerging roles of SIRT1 in fatty liver diseases. International Journal of Biological Sciences 13(7):852.","journal-title":"International Journal of Biological Sciences"},{"key":"2396_CR18","doi-asserted-by":"publisher","first-page":"108505","DOI":"10.1016\/j.jnutbio.2020.108505","volume":"87","author":"F Zamani-Garmsiri","year":"2021","unstructured":"Zamani-Garmsiri, F., et al. 2021. Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice. The Journal of Nutritional Biochemistry 87: 108505.","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"2396_CR19","doi-asserted-by":"publisher","first-page":"155638","DOI":"10.1016\/j.cyto.2021.155638","volume":"146","author":"M Aliabadi","year":"2021","unstructured":"Aliabadi, M. et al. 2021. Metformin in combination with genistein ameliorates skeletal muscle inflammation in high-fat diet fed c57BL\/6 mice. Cytokine 146:155638.","journal-title":"Cytokine"},{"key":"2396_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jnutbio.2019.02.001","volume":"67","author":"H-H Shen","year":"2019","unstructured":"Shen, H.-H., et al. 2019. Genistein ameliorated obesity accompanied with adipose tissue browning and attenuation of hepatic lipogenesis in ovariectomized rats with high-fat diet. The Journal of Nutritional Biochemistry 67: 111\u2013122.","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"2396_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109047","volume":"117","author":"X Xin","year":"2019","unstructured":"Xin, X., et al. 2019. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD). Biomedicine & Pharmacotherapy 117: 109047.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"2396_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95(2):351\u2013358.","journal-title":"Analytical Biochemistry"},{"key":"2396_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","volume":"25","author":"J Sedlak","year":"1968","unstructured":"Sedlak, J., and R. H. Lindsay. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with ellman\u2019s reagent. Analytical Biochemistry 25:192\u2013205.","journal-title":"Analytical Biochemistry"},{"issue":"18","key":"2396_CR24","doi-asserted-by":"publisher","first-page":"10227","DOI":"10.3390\/ijms231810227","volume":"23","author":"S Dilmac","year":"2022","unstructured":"Dilmac, S. et al. 2022. SIRT1\/FOXO signaling pathway in breast cancer progression and metastasis. International Journal of Molecular Sciences 23(18):10227.","journal-title":"International Journal of Molecular Sciences"},{"key":"2396_CR25","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl, A. M., and C. Day. 2017. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. New England Journal of Medicine 377:2063\u20132072.","journal-title":"New England Journal of Medicine"},{"key":"2396_CR26","doi-asserted-by":"crossref","unstructured":"Elhence, A. 2020. Treatment of non-alcoholic fatty liver disease\u2014Current perspectives. Indian Journal of Gastroenterology, : pp. 1\u201310.","DOI":"10.1007\/s12664-020-01021-2"},{"issue":"8","key":"2396_CR27","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.bbapap.2009.11.021","volume":"1804","author":"DJ Lomb","year":"2010","unstructured":"Lomb, D.J., G. Laurent, and M.C. Haigis. 2010. Sirtuins regulate key aspects of lipid metabolism. Biochimica et Biophysica Acta - Proteins and Proteomics 1804 (8): 1652\u20131657.","journal-title":"Biochimica et Biophysica Acta - Proteins and Proteomics"},{"issue":"4","key":"2396_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","volume":"9","author":"A Purushotham","year":"2009","unstructured":"Purushotham, A. et al. 2009. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metabolism 9(4):327\u2013338.","journal-title":"Cell Metabolism"},{"issue":"31","key":"2396_CR29","doi-asserted-by":"publisher","first-page":"12861","DOI":"10.1073\/pnas.0702509104","volume":"104","author":"JT Rodgers","year":"2007","unstructured":"Rodgers, J.T., and P. Puigserver. 2007. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proceedings of the National Academy of Sciences 104 (31): 12861\u201312866.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"2396_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.biopha.2017.04.130","volume":"91","author":"H Liu","year":"2017","unstructured":"Liu, H., et al. 2017. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats. Biomedicine & Pharmacotherapy 91: 964\u2013969.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"2396_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3109\/13880209.2013.766896","volume":"51","author":"E Arunkumar","year":"2013","unstructured":"Arunkumar, E., D. Karthik, and C.V. Anuradha. 2013. Genistein sensitizes hepatic insulin signaling and modulates lipid regulatory genes through p70 ribosomal S6 kinase-1 inhibition in high-fat\u2013high-fructose diet-fed mice. Pharmaceutical Biology 51 (7): 815\u2013824.","journal-title":"Pharmaceutical Biology"},{"issue":"9","key":"2396_CR32","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.nut.2005.12.014","volume":"22","author":"YM Lee","year":"2006","unstructured":"Lee, Y. M. et al. 2006. Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition (Burbank, Los Angeles County, Calif.) 22(9):956\u2013964.","journal-title":"Nutrition (Burbank, Los Angeles County, Calif.)"},{"key":"2396_CR33","doi-asserted-by":"crossref","unstructured":"Tian, C., R. Huang, and M. J. P. R. Xiang. 2024. SIRT1: harnessing multiple pathways to hinder NAFLD. : p. 107155.","DOI":"10.1016\/j.phrs.2024.107155"},{"key":"2396_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111552","volume":"139","author":"P Liu","year":"2021","unstructured":"Liu, P., et al. 2021. Hesperetin modulates the Sirt1\/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis. Biomedicine & Pharmacotherapy 139: 111552.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"19","key":"2396_CR35","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.3390\/nu14194017","volume":"14","author":"G Lu","year":"2022","unstructured":"Lu, G. et al. 2022. Resveratrol and FGF1 synergistically ameliorates Doxorubicin-Induced cardiotoxicity via activation of SIRT1-NRF2 pathway. Nutrients 14(19):4017.","journal-title":"Nutrients"},{"key":"2396_CR36","doi-asserted-by":"publisher","first-page":"120300","DOI":"10.1016\/j.lfs.2021.120300","volume":"291","author":"HH Arab","year":"2022","unstructured":"Arab, H. H. et al. 2022. Targeting oxidative stress, apoptosis, and autophagy by Galangin mitigates cadmium-induced renal damage: Role of SIRT1\/Nrf2 and AMPK\/mTOR pathways. Life Sciences 291:120300.","journal-title":"Life Sciences"},{"issue":"1","key":"2396_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbrc.2020.04.100","volume":"527","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. 2020. Genistein protects against acetaminophen-induced liver toxicity through augmentation of SIRT1 with induction of Nrf2 signalling. Biochemical and Biophysical Research Communications 527(1):90\u201397.","journal-title":"Biochemical and Biophysical Research Communications"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02396-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02396-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02396-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:02:40Z","timestamp":1792598560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02396-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2396"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02396-0","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"204"}}